Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery

被引:40
作者
Takakura, Y
Nishikawa, M
Yamashita, F
Hashida, M [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Sakyo Ku, Kyoto 6068501, Japan
关键词
in vivo gene delivery; pharmacokinetics; physicochemical properties; polyplex; lipoplex; receptor-mediated endocytosis;
D O I
10.1080/10611860290016694
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of physicochemical properties on the in vivo pharmacokinetics of gene delivery vectors after systemic administration is reviewed based on our studies. We have been studying the development of DNA delivery systems, such as plasmid DNA complexed with cationic polymers (polyplexes) and cationic liposomes (lipoplexes). Even if target-recognizable ligand is incorporated into the system, the overall physicochemical properties, notably size and charge, are predominant factors influencing in vivo disposition characteristics of the vector. Based on this consideration, liver cell-specific carrier systems via receptor-mediated endocytosis were successfully developed by optimizing physicochemical characteristics. In conclusion, rational design of gene delivery vectors requires an understanding of their pharmacokinetics in relation to the physicochemical properties. Optimization of the physicochemical properties is important for successful in vivo gene delivery by non-viral vectors.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 34 条
  • [1] Receptor-mediated gene transfer into macrophages
    Ferkol, T
    Perales, JC
    Mularo, F
    Hanson, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 101 - 105
  • [2] Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo
    He, YK
    Pimenov, AA
    Nayak, JV
    Plowey, J
    Falo, LD
    Huang, L
    [J]. HUMAN GENE THERAPY, 2000, 11 (04) : 547 - 554
  • [3] THE FATE OF PLASMID DNA AFTER INTRAVENOUS-INJECTION IN MICE - INVOLVEMENT OF SCAVENGER RECEPTORS IN ITS HEPATIC-UPTAKE
    KAWABATA, K
    TAKAKURA, Y
    HASHIDA, M
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (06) : 825 - 830
  • [4] In vivo gene delivery to the liver using novel galactosylated cationic liposomes
    Kawakami, S
    Fumoto, S
    Nishikawa, M
    Yamashita, F
    Hashida, M
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (03) : 306 - 313
  • [5] Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
    Kawakami, S
    Sato, A
    Nishikawa, M
    Yamashita, F
    Hashida, M
    [J]. GENE THERAPY, 2000, 7 (04) : 292 - 299
  • [6] Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes
    Kawakami, S
    Yamashita, F
    Nishikawa, M
    Takakura, Y
    Hashida, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (01) : 78 - 83
  • [7] Tumor targeting with surface-shielded ligand-polycation DNA complexes
    Kircheis, R
    Blessing, T
    Brunner, S
    Wightman, L
    Wagner, E
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) : 165 - 170
  • [8] Kobayashi N, 2001, J PHARMACOL EXP THER, V297, P853
  • [9] 2-IMINO-2-METHOXYETHYL 1-THIOGLYCOSIDES - NEW REAGENTS FOR ATTACHING SUGARS TO PROTEINS
    LEE, YC
    STOWELL, CP
    KRANTZ, MJ
    [J]. BIOCHEMISTRY, 1976, 15 (18) : 3956 - 3963
  • [10] Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection
    Li, S
    Tseng, WC
    Stolz, DB
    Wu, SP
    Watkins, SC
    Huang, L
    [J]. GENE THERAPY, 1999, 6 (04) : 585 - 594